BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 25597396)

  • 1. Differential remodeling of extracellular matrices by breast cancer initiating cells.
    Raja AM; Xu S; Zhuo S; Tai DC; Sun W; So PT; Welsch RE; Chen CS; Yu H
    J Biophotonics; 2015 Oct; 8(10):804-15. PubMed ID: 25597396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival and self-renewing capacity of breast cancer initiating cells during fractionated radiation treatment.
    Lagadec C; Vlashi E; Della Donna L; Meng Y; Dekmezian C; Kim K; Pajonk F
    Breast Cancer Res; 2010; 12(1):R13. PubMed ID: 20158881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer-initiating cells from colorectal cancer patients escape from T cell-mediated immunosurveillance in vitro through membrane-bound IL-4.
    Volonté A; Di Tomaso T; Spinelli M; Todaro M; Sanvito F; Albarello L; Bissolati M; Ghirardelli L; Orsenigo E; Ferrone S; Doglioni C; Stassi G; Dellabona P; Staudacher C; Parmiani G; Maccalli C
    J Immunol; 2014 Jan; 192(1):523-32. PubMed ID: 24277698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spelling Out CICs: A Multi-Organ Examination of the Contributions of Cancer Initiating Cells' Role in Tumor Progression.
    Baisiwala S; Budhiraja S; Goel C; Nandoliya KR; Saathoff MR; Ahmed AU
    Stem Cell Rev Rep; 2022 Jan; 18(1):228-240. PubMed ID: 34244971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible role of mural cell-covered mature blood vessels in inducing drug resistance in cancer-initiating cells.
    Matsui T; Kinugasa Y; Tahara H; Kanakura Y; Takakura N
    Am J Pathol; 2013 May; 182(5):1790-9. PubMed ID: 23473746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lunasin is a novel therapeutic agent for targeting melanoma cancer stem cells.
    Shidal C; Al-Rayyan N; Yaddanapudi K; Davis KR
    Oncotarget; 2016 Dec; 7(51):84128-84141. PubMed ID: 27566591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small proline-rich protein-1B is overexpressed in human oral squamous cell cancer stem-like cells and is related to their growth through activation of MAP kinase signal.
    Michifuri Y; Hirohashi Y; Torigoe T; Miyazaki A; Fujino J; Tamura Y; Tsukahara T; Kanaseki T; Kobayashi J; Sasaki T; Takahashi A; Nakamori K; Yamaguchi A; Hiratsuka H; Sato N
    Biochem Biophys Res Commun; 2013 Sep; 439(1):96-102. PubMed ID: 23954638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of MHC-I expression limits T-lymphocyte-mediated killing of Cancer-initiating cells.
    Morrison BJ; Steel JC; Morris JC
    BMC Cancer; 2018 Apr; 18(1):469. PubMed ID: 29699516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment and Analysis of Cancer Stem-Like and Non-Cancer Stem-Like Clone Cells from the Human Colon Cancer Cell Line SW480.
    Takaya A; Hirohashi Y; Murai A; Morita R; Saijo H; Yamamoto E; Kubo T; Nakatsugawa M; Kanaseki T; Tsukahara T; Tamura Y; Takemasa I; Kondo T; Sato N; Torigoe T
    PLoS One; 2016; 11(7):e0158903. PubMed ID: 27415781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sphere culture of murine lung cancer cell lines are enriched with cancer initiating cells.
    Morrison BJ; Steel JC; Morris JC
    PLoS One; 2012; 7(11):e49752. PubMed ID: 23152931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the cancer initiating cell: the ultimate target for cancer therapy.
    McCubrey JA; Steelman LS; Abrams SL; Misaghian N; Chappell WH; Basecke J; Nicoletti F; Libra M; Ligresti G; Stivala F; Maksimovic-Ivanic D; Mijatovic S; Montalto G; Cervello M; Laidler P; Bonati A; Evangelisti C; Cocco L; Martelli AM
    Curr Pharm Des; 2012; 18(13):1784-95. PubMed ID: 22394167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ectopically expressed variant form of sperm mitochondria-associated cysteine-rich protein augments tumorigenicity of the stem cell population of lung adenocarcinoma cells.
    Takahashi A; Hirohashi Y; Torigoe T; Tamura Y; Tsukahara T; Kanaseki T; Kochin V; Saijo H; Kubo T; Nakatsugawa M; Asanuma H; Hasegawa T; Kondo T; Sato N
    PLoS One; 2013; 8(11):e69095. PubMed ID: 24244262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Collagen reorganization at the tumor-stromal interface facilitates local invasion.
    Provenzano PP; Eliceiri KW; Campbell JM; Inman DR; White JG; Keely PJ
    BMC Med; 2006 Dec; 4(1):38. PubMed ID: 17190588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated collagen-I augments tumor progressive signals, intravasation and metastasis of prolactin-induced estrogen receptor alpha positive mammary tumor cells.
    Barcus CE; O'Leary KA; Brockman JL; Rugowski DE; Liu Y; Garcia N; Yu M; Keely PJ; Eliceiri KW; Schuler LA
    Breast Cancer Res; 2017 Jan; 19(1):9. PubMed ID: 28103936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged drug selection of breast cancer cells and enrichment of cancer stem cell characteristics.
    Calcagno AM; Salcido CD; Gillet JP; Wu CP; Fostel JM; Mumau MD; Gottesman MM; Varticovski L; Ambudkar SV
    J Natl Cancer Inst; 2010 Nov; 102(21):1637-52. PubMed ID: 20935265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential regulation of the sphere formation and maintenance of cancer-initiating cells of malignant mesothelioma via CD44 and ALK4 signaling pathways.
    Ohno Y; Shingyoku S; Miyake S; Tanaka A; Fudesaka S; Shimizu Y; Yoshifuji A; Yamawaki Y; Yoshida S; Tanaka S; Sakura K; Tanaka T
    Oncogene; 2018 Dec; 37(49):6357-6367. PubMed ID: 30061637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD133/Src axis mediates tumor initiating property and epithelial-mesenchymal transition of head and neck cancer.
    Chen YS; Wu MJ; Huang CY; Lin SC; Chuang TH; Yu CC; Lo JF
    PLoS One; 2011; 6(11):e28053. PubMed ID: 22140506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acquisition of tumorigenic potential and enhancement of angiogenesis in pulmonary stem/progenitor cells through Oct-4 hyperexpression.
    Gu SY; Ho CC; Huang YK; Chen HW; Wang YC; Kuo CY; Teng SC; Fu WM; Yang PC; Wu CW; Peng FC; Ling TY
    Oncotarget; 2016 Mar; 7(12):13917-31. PubMed ID: 26871601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the cancer initiating cell: the Achilles' heel of cancer.
    McCubrey JA; Chappell WH; Abrams SL; Franklin RA; Long JM; Sattler JA; Kempf CR; Laidler P; Steelman LS
    Adv Enzyme Regul; 2011; 51(1):152-62. PubMed ID: 21035484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FAP-overexpressing fibroblasts produce an extracellular matrix that enhances invasive velocity and directionality of pancreatic cancer cells.
    Lee HO; Mullins SR; Franco-Barraza J; Valianou M; Cukierman E; Cheng JD
    BMC Cancer; 2011 Jun; 11():245. PubMed ID: 21668992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.